We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$254M
AUM Growth
+$22.2M
Cap. Flow
+$5.01M
Cap. Flow %
1.97%
Top 10 Hldgs %
45.13%
Holding
116
New
12
Increased
26
Reduced
50
Closed
24

Top Buys

Rank Stock Value
1
LENZ
LENZ Therapeutics
LENZ
+$20.9M
2
BOLD
Boundless Bio
BOLD
+$12.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$3.72M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.08M
5
PGNY icon
Progyny
PGNY
+$2.87M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.69M
2
EWTX icon
Edgewise Therapeutics
EWTX
+$3.59M
3
ANNX icon
Annexon
ANNX
+$2.96M
4
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.89M
5
VERA icon
Vera Therapeutics
VERA
+$2.82M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$162B
$2.84M 1.11%
38,705
-2,200
-5% -$169K
ALNY icon
27
Alnylam Pharmaceuticals
ALNY
$27.5B
$2.76M 1.08%
18,460
-4,180
-18% -$697K
ICLR icon
28
Icon
ICLR
$12.6B
$2.67M 1.05%
7,943
-2,260
-22% -$666K
CNC icon
29
Centene
CNC
$30.7B
$2.67M 1.05%
+34,000
New +$2.63M
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
$2.6M 1.02%
221,044
+64,275
+41% +$822K
NARI
31
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.52M 0.99%
+52,500
New +$2.8M
ISRG icon
32
Intuitive Surgical
ISRG
$127B
$2.43M 0.96%
+6,100
New +$2.3M
SYK icon
33
Stryker
SYK
$125B
$2.36M 0.93%
+6,600
New +$2.22M
MLTX icon
34
MoonLake Immunotherapeutics
MLTX
$1.57B
$2.33M 0.91%
46,295
+16,290
+54% +$884K
GDRX icon
35
GoodRx Holdings
GDRX
$1.04B
$2.28M 0.9%
321,000
-43,000
-12% -$284K
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.57B
$2.24M 0.88%
17,291
-4,250
-20% -$521K
OPCH icon
37
Option Care Health
OPCH
$3.45B
$2.15M 0.84%
64,000
– –
SPRY icon
38
ARS Pharmaceuticals
SPRY
$509M
$2.09M 0.82%
204,437
-150,204
-42% -$1.12M
ARVN icon
39
Arvinas
ARVN
$518M
$2.01M 0.79%
48,780
-17,220
-26% -$752K
VERA icon
40
Vera Therapeutics
VERA
$2.3B
$1.94M 0.76%
44,901
-79,250
-64% -$2.82M
EYPT icon
41
EyePoint Inc
EYPT
$1.03B
$1.91M 0.75%
92,340
+11,180
+14% +$277K
ATEC icon
42
Alphatec Holdings
ATEC
$1.46B
$1.88M 0.74%
+136,000
New +$2.02M
ITOS
43
DELISTED
iTeos Therapeutics
ITOS
$1.83M 0.72%
133,966
-86,090
-39% -$938K
ELV icon
44
Elevance Health
ELV
$81.5B
$1.81M 0.71%
+3,500
New +$1.74M
COGT icon
45
Cogent Biosciences
COGT
$6.65B
$1.77M 0.7%
+263,700
New +$1.63M
RCUS icon
46
Arcus Biosciences
RCUS
$3.55B
$1.77M 0.7%
93,635
-3,800
-4% -$65.7K
AZN icon
47
AstraZeneca
AZN
$263B
$1.66M 0.65%
12,215
-850
-7% -$113K
HUM icon
48
Humana
HUM
$43.7B
$1.65M 0.65%
4,751
-3,474
-42% -$1.32M
SLRN
49
DELISTED
ACELYRIN
SLRN
$1.65M 0.65%
244,000
-81,549
-25% -$619K
OLMA icon
50
Olema Pharmaceuticals
OLMA
$1B
$1.58M 0.62%
139,980
+120,750
+628% +$1.56M
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sectoral Asset Management held 116 positions worth $254M, up 9.5% from $232M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sectoral Asset Management's Q1 2024 filing shows 12 new, 26 increased, 50 reduced and 24 closed positions. Its largest new stake was Boundless Bio: 855,875 shares worth $12.2M. The largest sale was Amgen, an estimated $3.69M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Sectoral Asset Management's largest Q1 2024 buy was Boundless Bio: 855,875 shares worth $12.2M.
  • Sectoral Asset Management added most to LENZ Therapeutics in Q1 2024, an estimated $20.9M increase.
  • Sectoral Asset Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $3.69M.
  • Sectoral Asset Management fully exited Edgewise Therapeutics in Q1 2024, selling an estimated $3.59M.
  • Sectoral Asset Management's ten largest holdings make up 45% of its $254M portfolio in Q1 2024.
  • Sectoral Asset Management opened 12 new positions and closed 24 in Q1 2024.
  • Sectoral Asset Management's portfolio value rose 9.5% quarter-over-quarter to $254M.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.